Expert: Consumers Need More Info on Complex Drug Benefits
Employer-sponsored plans have “increasingly complex” prescription drug cost-sharing arrangements, according to the Kaiser Family Foundation’s (KFF) 2020 Employer Health Benefits Survey. But one expert says tha...
News Briefs
✦ HHS and the Dept. of Defense reached a deal with CVS Health Corp. and Walgreen Co. to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) nationwide, with no out-of-pocket c...
SCOTUS Hearing Hints at PBM Win in Case Against State Regs
Following an Oct. 6 Supreme Court hearing, legal experts tell AIS Health that PBMs appear to have a good shot at prevailing in their challenge of a 2015 Arkansas law, which has major implications for how both health...
CVS, Optum Exclude Inhalers, Switch Diabetes Supplies for ’21 With Chart: Major PBMs Release 2021 Formulary Exclusions
Editor's Note: A previous version of this article misstated how OptumRx is covering Tecfidera, Ruxience, Rituxan and Truxima. This version has been corrected.
CVS Health Corp.’s Caremark will exclude 57 medicat...
UnitedHealth Reportedly Moves to Buy PillPack Competitor
More than two years after Amazon Inc. unveiled its plan to acquire PillPack, which specializes in pre-sorted dose packaging and home delivery of prescription drugs (RDB 7/13/18, p. 1), UnitedHealth Group has reporte...
Experts Slam Trump’s $200 Medicare Drug Card Proposal
Experts say a last-minute proposal by President Donald Trump to distribute $200 prescription drug credits to Medicare Part D enrollees on preloaded debit cards faces many unanswered questions and will be difficult t...
News Briefs
✦ Manufacturer prices for insulin in the United States were “considerably” — often five or 10 times — higher than those in other Organisation for Economic Co-operation and Development countries, according ...
Demos Could Result From ‘Most Favored Nation’ Order
The Trump administration’s long-awaited executive order that seeks to tie U.S. drug prices to costs in other countries may represent more presidential campaign talking points than real policy that will take effect...
Execs Detail Payers’ Role in COVID-19 Vaccine Distribution
As the pharmaceutical industry hurtles toward completing a COVID-19 vaccine, payers and PBMs have begun to draft vaccine distribution plans based on emerging guidance from federal public health leaders. Insurance in...
New Process Might Help Make CAR-T Therapies Less Expensive
This summer, a drug called Tecartus (brexucabtagene autoleucel) became the third chimeric antigen receptor T-cell (CAR-T) therapy approved by the FDA. CAR-T therapies, which use a patient’s genetically modified im...